SPOTLIGHT: Zyrtec-D gets cleared for OTC sale


Prescription Zyrtec-D is dead! Long live Zyrtec-D! The FDA will allow Johnson & Johnson--which owns over-the-counter rights to the allergy med--to sell Zyrtec-D without a prescription, a move that will undoubtedly cut into Pfizer's sales of the prescription form. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.